Kalincik, T. Et Al. 2015. Switch to Natalizumab versus Fingolimod in Active Relapsing-Remitting Multiple Sclerosis. ANNALS OF NEUROLOGY , vol.77, no.3 , 425-435.

Kalincik, T., Horakova, D., Spelman, T., Jokubaitis, V., Trojano, M., Lugaresi, A., ... Izquierdo, G.(2015). Switch to Natalizumab versus Fingolimod in Active Relapsing-Remitting Multiple Sclerosis. ANNALS OF NEUROLOGY , vol.77, no.3, 425-435.

Kalincik, Tomas Et Al. "Switch to Natalizumab versus Fingolimod in Active Relapsing-Remitting Multiple Sclerosis," ANNALS OF NEUROLOGY , vol.77, no.3, 425-435, 2015

Kalincik, Tomas Et Al. "Switch to Natalizumab versus Fingolimod in Active Relapsing-Remitting Multiple Sclerosis." ANNALS OF NEUROLOGY , vol.77, no.3, pp.425-435, 2015

Kalincik, T. Et Al. (2015) . "Switch to Natalizumab versus Fingolimod in Active Relapsing-Remitting Multiple Sclerosis." ANNALS OF NEUROLOGY , vol.77, no.3, pp.425-435.

@article{article, author={Tomas Kalincik Et Al. }, title={Switch to Natalizumab versus Fingolimod in Active Relapsing-Remitting Multiple Sclerosis}, journal={ANNALS OF NEUROLOGY}, year=2015, pages={425-435} }